⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8501185 | 0.68 | — | — | |
| Methoxymethane SCHEMBL5707121 | 0.61 | — | — | |
| Methoxymethane SCHEMBL868 | 0.61 | — | — | |
| Methoxymethane SCHEMBL12190176 | 0.61 | — | — | |
| Methoxymethane SCHEMBL16998540 | 0.61 | — | — | |
| SCHEMBL10456665 | 0.58 | — | — | |
| SCHEMBL28095 | 0.58 | — | — | |
| Methoxymethane SCHEMBL23668283 | 0.55 | — | — | |
| Methoxymethane SCHEMBL1281599 | 0.55 | — | — | |
| Methoxymethane SCHEMBL10891136 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025123046-A1 | SYNTHESIS OF LEUCINE-RICH REPEAT KINASE 2 MODULATORS | ARVINAS OPERATIONS, INC. (US) | 2025-06-12 | — | — | WO | claimed |
| CN-118255751-A | Preparation method of RAF kinase inhibitor | 齐鲁制药有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-118108753-A | N, N-dialkyl thioformyl-containing 2-silicon-based indole or pyrrole compound and synthesis method and application thereof | 杭州师范大学 | 2024-05-31 | — | — | CN | claimed |
| CN-112824381-B | Preparation method of piperidine amine | 广东东阳光药业股份有限公司 | 2024-04-26 | — | — | CN | claimed |
| EP-4743084-A1 | AZAINDOLE DERIVATIVES WITH A CYCLO(HETERO)ALIPHATIC RING AND THEIR USE AS ERK KINASE INHIBITORS | IPSEN PHARMA (FR) | 2026-05-20 | — | — | EP | disclosed |
| EP-4743177-A1 | FLUORINATED AZAINDOLE DERIVATIVES AND THEIR USE AS ERK KINASE INHIBITORS | IPSEN PHARMA (FR) | 2026-05-20 | — | — | EP | disclosed |
| US-12630566-B2 | KRas G12D inhibitors | Mirati Therapeutics, Inc. (US) | 2026-05-19 | — | — | US | disclosed |
| WO-2026098567-A1 | MACROCYCLIC COMPOUNDS AND USE THEREOF | 微境生物医药科技(上海)有限公司 | 2026-05-15 | — | — | WO | disclosed |
| EP-4705291-A1 | IKK-ALPHA INHIBITORS | Cancer Research Technology Limited (GB) | 2026-03-11 | — | — | EP | disclosed |
| EP-4626554-A1 | GLUTARIMIDE-CONTAINING KRAS-MUTANT DEGRADER COMPOUNDS AND USES THEREOF | Tiger Biotherapeutics Inc. (US) | 2025-10-08 | — | — | EP | disclosed |
| US-12391679-B2 | Benzamide-substituted bicyclic imidazo- and pyrazolo-fused -pyridine, -pyrimide, and -pyridazine compounds for treatment of inflammatory diseases | ONCO3R THERAPEUTICS BV (BE) | 2025-08-19 | — | — | US | disclosed |
| US-20250197381-A1 | SUBSTITUTED TETRAHYDROFURANS AS MODULATORS OF SODIUM CHANNELS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2025-06-19 | — | — | US | disclosed |
| US-20220144823-A1 | PYRAZOLOPYRIDINE DERIVATIVES AS INHIBITORS OF PASK | GALAPAGOS NV (BE) | 2022-05-12 | — | — | US | disclosed |
| CN-112513041-B | Tricyclic compounds | 北京加科思新药研发有限公司 | 2022-05-10 | — | — | CN | disclosed |
| US-11312715-B2 | Fused ring derivative as A2A receptor inhibitor | CSTONE PHARMACEUTICALS (SUZHOU) CO., LTD. (CN) | 2022-04-26 | — | — | US | disclosed |
| WO-2022070289-A1 | NITROGEN-CONTAINING BICYCLIC COMPOUND WHICH CONTAINS PYRIMIDINE | 旭化成ファーマ株式会社 | 2022-04-07 | — | — | WO | disclosed |
| WO-2022070288-A1 | NITROGEN-CONTAINING BICYCLIC COMPOUND | 旭化成ファーマ株式会社 | 2022-04-07 | — | — | WO | disclosed |
| CN-113423707-A | ERK inhibitors and uses thereof | 加利福尼亚技术学院 | 2021-09-21 | — | — | CN | disclosed |
| CN-110437230-A | A kind of three-level aminated compounds and biphosphine ligand, wherein mesosome and preparation method | SHANGHAI INST ORGANIC CHEMISTRY CAS | 2019-11-12 | — | — | CN | disclosed |
| WO-2019000237-A1 | 3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF M4 MUSCARINIC ACETYLCHOLINE RECEPTOR | MERCK SHARP & DOHME CORP. (US) | 2019-01-03 | — | — | WO | disclosed |